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Polymerase chain reaction (PCR) is an in vitro technique for the nucleic acid amplification, which is commonly used
to diagnose infectious diseases. The use of PCR for pathogens detection, genotyping and quantification has some
advantages, such as high sensitivity, high specificity, reproducibility and technical ease. Brucellosis is a common
zoonosis caused by Brucella spp., which still remains as a major health problem in many developing countries around the
world. The direct culture and immunohistochemistry can be used for detecting infection with Brucella spp. However, PCR
has the potential to address limitations of these methods. PCR are now one of the most useful assays for the diagnosis in
human brucellosis. The aim of this review was to summarize the main PCR techniques and their applications for
diagnosis and follow-up of patients with brucellosis. Moreover, advantages or limitation of the different PCR methods
as well as the evaluation of PCR results for treatment and follow-up of human brucellosis were also discussed.
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Brucellosis is a widespread zoonotic disease caused by
members of genus Brucella. Its prevalence is more than
10 per 100 000 population in some endemic countries
[1]. Transmission of brucellosis from animals to humans
occurs mainly through direct contact with infected animals,
ingestion of raw dairy products of animal origin, or
consumption of infected meat from domestic livestock
[2]. Human brucellosis may lead to a variety of clinical
presentations, such as fever, sweating, chills, headache,
malaise, myalgia and even arthralgia of the large joints
[3]. The presentations and phases of the disease may be
acute, sub-acute, chronic, relapsed, active or inactive.
Antibiotic treatment of human brucellosis often results
in high treatment failure and relapse rates. Because the
clinical presentation is non-specific, laboratory testing
is required for confirmation.
Brucella species are gram-negative, facultative intracel-
lular bacteria, which lack capsules, flagellae, endospores
or native plasmids [4]. Currently, the genus Brucella
consists of ten species: B. abortus, B. suis, B. ovis, B.
melitensis, B. canis, B. neotomae, B. pinnipedialis, B.
ceti, B. microti and B. inopinata [5]. Four species of the* Correspondence: mxtisme@126.com; huiyu2008@hotmail.com
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unless otherwise stated.genus Brucella are pathogenic for humans, namely B.
melitensis, B. abortus, B. suis, and B. canis. B. melitensis
is considered as the most pathogenic species, followed by
B. suis, whereas B. abortus is the mildest type of brucellosis.
Additionally, Brucella isolates from marine mammals can
cause human infections. DNA-DNA hybridization studies
demonstrated that there are high degrees of genetic similar-
ity of Brucella spp. [6].
At present, there are various assays for diagnosis of
human brucellosis such as standard microbiological tests
for the isolation of Brucella spp. from blood, tissue spec-
imens, body fluids and bone marrow, serological tests
for the detection of anti-Brucella spp. antibodies and
molecular methods for the detection of Brucella spp.
DNA [7]. The most commonly used methods for detec-
tion and segregation of Brucella spp. were culture
techniques and serological tests (standard agglutin-
ation tube test, anti-human globulin test, Rose-Bengal
test, mercaptan-based tests, enzyme-linked immunosorbent
assay and brucellacapt) [8,9]. However, isolation of Brucella
spp. is associated with a risk of laboratory-acquired infec-
tions and time consuming, and culture sampling sensitiv-
ity is often low, depending on the culture medium,
Brucella species, disease stage and quantity of circulating
bacteria. Serological tests seem to be more effective but
can be unspecific due to cross reaction or subsensitivetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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ical prevalence of brucellosis [10]. The principles and
the main applications of these methods have been well
reviewed elsewhere [11].
To ensure effective brucellosis disease prevention and
control, a fast and accurate identification method is
necessary. Polymerase chain reaction (PCR) technique
offers a sensitive and specific way of detecting Brucella
spp. from peripheral blood and other tissues [12]. The
first brucellosis PCR-based test was introduced by Fekete
et al. in 1990 [13]. They successfully amplified a 635 bp
fragment of a 43 kDa outer membrane protein gene
from B. abortus strain 19. Several studies have reported
that PCR is a very useful tool for the rapid diagnosis of
acute brucellosis and a good marker for the posttreatment
follow-up and the early detection of relapses [14,15].
Moreover, many studies have developed PCR-based assays
to differentiate 10 Brucella species [16-18]. Up to data,
PCR assays have been used in diagnosis of both animal
brucellosis and human brucellosis [19]. To our current
knowledge, at least 200 reports have been published
dealing with various methods based on PCR for labora-
tory diagnosis of human brucellosis. This review article
highlights various PCR-based methods for the clinical
diagnosis of human brucellosis. The principles, advan-
tages or limitation of the different methods are also be-
ing discussed together with examples of applications
taken from the literatures.
Standard PCR
For the diagnosis of human brucellosis, a PCR assay
with one pair of primers was developed, which amplifies
the target genomic sequence of Brucella species. Primer
pairs include the primers for sequences encoding 16S
rRNA [20,21], outer membrane protein (omp2a, omp2b)
[22-24], 31-kDa immunogenic Brucella abortus protein
(BCSP 31) [25,26], 16S-23S ribosomal DNA interspace
region [27] and insertion sequence (IS711) [28,29]. Studies
showed that standard PCR appeared to be a more sensi-
tive technique than microbiological methods, not only for
the diagnosis of a first episode of infection, but also for
the early detection of relapses [30-32]. Some research
groups also assessed the performances of standard PCR as
diagnostic tools for human brucellosis with respect to
conventional methods. Their results showed that standard
PCR is a promising diagnostic tool for patients with
clinical signs and symptoms, and negative serological
results, allowing an accurate and early diagnosis of
human brucellosis [33,34].
The standard PCR is simple and efficient. However,
efficiency of this method is dependent on the specificity
of the primers. Different primer pairs have previously
been published for Brucella spp. detection, and only a
few of them have been used in human samples. BaddourMM et al. compared sensitivity of 3 pairs of primers
amplify 3 different fragments including a gene encoding
BCSP 31 (B4/B5), a sequence 16S rRNA of B. abortus
(F4/R2), and a gene encoding omp2 (JPF/JPR). The results
showed that the sensitivity of the B4/B5 primer pair,
JPF/JPR primer pair and F4/R2 primer pair was 98%,
88.4% and 53.1%, respectively [35]. Navarro et al. also
compared PCR methods using these 3 pairs of primers
as described above. Their results further indicated that
the three primers assayed showed a difference in sensitiv-
ity by the presence of human genomic DNA [36]. Table 1
showed the efficiency of blood PCR assays using different
primers.
In fact, blood samples are often used for the diagnosis
of human brucellosis by the standard PCR [37]. Several
factors were reported to affect PCR results in a blood
specimen such as the high concentrations of leukocytes
DNA and heme compounds [38]. Additionally, human
genomic DNA affect the sensitivity of peripheral-blood
PCR assay for the detection of Brucella DNA [36]. Zerva
L et al. reported that serum samples should be used
preferentially over whole blood for diagnosis of human
brucellosis by PCR [39], but Mitka S et al. revealed that
buffy coat and whole blood were the optimal specimens
[14]. Moreover, sample volume used and efficient DNA
extraction protocol are also the points of concern for the
standard PCR to be used in routine laboratory testing
for human brucellosis [34].
Real time PCR
Compared with the standard PCR, real-time PCR is a
valuable technique in determining the quantification of
nucleic acids in individual blood samples, as well as in
automating the data. With the decreasing prices of real-
time PCR thermocyclers and the reagents, many more
people now have access to this technology to measure
DNA copy number, mRNA expression levels and viral titers
[40]. Recently, real-time PCR for the rapid detection and
differentiation of Brucella species in clinical samples has
recently been developed, targeting 16S-23S internal tran-
scribed spacer region (ITS) and the genes coding omp25
and omp31 [41], BCSP 31 [42-44], and IS711 [45,46].
Real-time PCR seems to be highly reproducible, rapid,
sensitive and specific. Additionally, this assay is easily
standardized and minimises the risk of infection in labora-
tory workers. It is therefore a useful method for both the
initial diagnosis of human brucellosis and the differenti-
ation among inactive, seropositive, and active states.
Queipo-Ortuño et al. reported that the sensitivities of a
SYBR Green I LightCycler-based real-time PCR assay with
serum samples was 93.3%, which is higher than 90% and
65% obtained by PCR-ELISA with whole blood samples
and blood cultures, respectively [47]. This group further
developed a LightCycler-based real-time PCR assay to
Table 1 Efficiency of blood PCR assays





B4 TGGCTCGGTTGCCAATATCAA bcsp31 100 100 100 98 14
B5 CGCGCTTGCCTTTCAGGTCTG
JPF GCGCTCAGGCTGCCGACGCAA omp2 98 100 100 96.1 14
JPR ACCAGCCATTGCGGTCGGTA
P1 TGGAGGTCAGAAATGAAC omp2 99 100 100 98 14
P2 GAGTGCGAAACGAGCGC
26A GCCCCTGACATAACCCGCTT bp26 98.5 100 100 97.1 14
26B GAGCGTGACATTTGCCGATA
F4 TCGAGCGCCCGCAAGGGG 16S 53.1 100 53.1 100 35
R2 AACCATAGTGTCTCCACTAA rRNA
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found to be 91.9% sensitive and 95.4% specific when tested
with 65 negative control samples and 62 serum samples
from patients with active brucellosis [48].
Furthermore, Surucuoglu S et al. compared the TaqMan
real time PCR technique to conventional methods using
serum samples from patients with different clinical forms
of brucellosis. The sensitivity, specificity, positive and
negative predictive values of this PCR method were
calculated as 88%, 100%, 100%, and 83%, respectively
[49]. Alsayed Y et al. further investigated the potential
of a combination of several tests (culture, ELISA and
real-time PCR) to support the diagnosis in different
clinical manifestations of brucellosis with peripheral
blood samples. They found that if the agglutination test is
negative, real-time PCR, and/or ELISA, and/or culture are
recommended [50]. Moreover, using a panel of seven
primer sets, Winchell JM et al. developed a real-time PCR
method to differentiate members of the Brucella genus
isolates, and has the potential to detect novel species [51].
Other studies also reported that real-time PCR allowed
the rapid diagnosis of human brucellosis [52,53]. These
results suggest that the high species specificity and se-
lectivity of real-time PCR assay make it a useful tool
for diagnosis of human brucellosis.
Just as standard PCR, efficiency of real-time PCR is
also dependent on the specificity of the primers. Kattar
MM et al. developed three real-time PCRs for diagnosis
of human brucellosis at genus level with hybridization
probes and primers from 16S-23S ITS, omp25 and omp31.
Their results showed that real-time PCR with 16S-23S ITS
primers and its probes was the most sensitive, indicating
its potential for the diagnosis of human brucellosis in the
clinical laboratory [41]. Additionally, a study analyzed the
sensitivity and specificity of the 3 established real-time
PCR methods using primers and TaqMan probes targeting
the IS711, bcsp31 and per genes, and it also compared
their efficiencies for the detection of the Brucella genus.The results showed that the IS711-based real-time PCR
was the most sensitive, specific and efficient to detect
Brucella spp. [54]. Table 2 showed that the sensitivity of
the IS711 target was identical or 10 times higher that
the sensitivity of the two other targets [54]. Moreover,
the influences of other factors involved in the efficiency
of the amplification process of real-time PCR for the
diagnosis of human brucellosis were also reported, such
as immunoglobulin G, which were extracted with the
template DNA from serum samples [55].
Multiplex PCR
To overcome the inherent disadvantage of cost of the
test, multiplex PCR has been developed to detect viral,
bacterial, and/or other infectious agents. The advantages
of using multiplex PCR technique are that it minimizes
expense and recognizes many pathogens at once [56].
These advances have resulted in the appearance of numer-
ous publications regarding the application of multiplex
PCR in the diagnosis of human brucellosis.
Lübeck PS et al. developed and applied a multiplex
PCR assay for Brucella diagnostics based on the perosa-
mine synthetase gene in 2003 [57]. El Kholy AA et al.
also established a multiplex PCR technique using 2 sets
of primers (B4/B5 and JPF/JPR) for the diagnosis of
active human brucellosis in Egypt [58]. They found that
this technique showed high sensitivity, specificity and
accuracy, and could serve as important alternatives to cul-
ture methods for diagnosis of human brucellosis. Addition-
ally, a multiplex PCR assay can be used to simultaneously
detect and type Brucella species present in clinical samples.
In 2007, Imaoka K et al. developed a multiplex PCR pro-
cedure to identify four major species of the genus Brucella
in one reaction tube. Four pairs of primers targeting bcsp31,
omp2b, omp2a and omp31 genes were used. The specific
amplification for each Brucella spp. examined in this study
was achieved with these primers [59]. Other groups also
reported robust and rapid multiplex PCR assays, which
Table 2 Comparison of conventional and real-time PCR assays lower limit of detection (fg)
Brucella IS711 copy number Conventional PCR Real-time PCR
IS711 bcsp31 per IS711 bcsp31 per
B. canis RM6/66 6 100 1000 1000 2 20 20
B. abortus 544 7 100 1000 1000 2 2 2
B. melitensis 16 M 7 1000 1000 1000 2 20 20
B. ovis 63/290 38 100 1000 1000 0.2 2 2
(This table was taken from ref. [54]).
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Brucella species in a single test of less than an hour and a
half [60-65]. The timely and accurate information pro-
vided by this assay would be valuable to trace sources of
infection and may help in rapid diagnosis of human bru-
cellosis. Furthermore, several multiplex PCRs have been
described for identification of Brucella partly at the biovar
level using different primer combinations. A 19-primer
multiplex PCR specifically identified B. neotomae, B. pin-
nipedialis, B. ceti, and B. microti simultaneously. Also, this
method was able to differentiate B. abortus biovars 1, 2, 4
from biovars 3, 5, 6, 9 [66]. A novel multiplex PCR assay
for the rapid detection of Brucella genus at the species
and at the biovar level has been described. The assay was
shown to be ideal method for detection of B. suis at the
biovar level and the differentiation of B. suis, B. canis and
B. microti [67]. It is well knows that only a few biovars of
Brucella species are pathogenic for humans, hence rapid
identification of Brucella genus at the biovar level is
necessary. Moreover, several multiplex PCRs have been de-
scribed for the simultaneous detection of Mycobacterium
tuberculosis (M. tuberculosis) complex and Brucella spp.,
targeting the IS711, bcsp31 and omp2a genes for the identi-
fication of Brucella spp. and the IS6110, senX3-regX3 and
cfp31 genes for the detection of the M. tuberculosis com-
plex [68-70]. The results showed that this technique was a
practical approach for the differential diagnosis between
extrapulmonary tuberculosis and complicated brucellosis.
The primer pairs have substantial effect on the multi-
plex PCR efficiency. The presence of more than one
primer pair in the multiplex PCR increases risk for
primer-dimers. Thus, nonspecific products may be ob-
tained [71]. Ideally, all the primer pairs in a multiplex
PCR should not only eliminate non-specific PCR prod-
ucts, but also enable similar amplification efficiencies for
their respective target. Therefore, the multiplex PCR re-
quires laborious optimization [72].
Nested and semi-nested PCR
The nested PCR means that two different pairs of PCR
primers are used for a single locus. The first pair is an
amplified sequence. The second pair of primers (nested
primers) is complementary to the sequence amplified by
the first pair primers and produces a second PCR productthat will be shorter than the first one [73]. Same as nested,
semi-nested PCR has two different pairs of PCR primers,
but the second pair of primers has one primer identical to
the first pair [74]. The nested PCR and semi-nested PCR
amplify only the specific sequences sought and are more
specific than the standard PCR. Recently, nested PCR and
semi-nested PCR assays were developed for identifying
Brucella in samples of human blood and then to ex-
plore their clinical practice for the diagnosis of human
brucellosis.
Two nested PCR assays have been applied for the
diagnosis of human brucellosis in Kuwait. Two pairs of
primers derived from IS711 were used. The results showed
that the use of nested primers gave increased sensitivity
and higher specificity providing a better molecular diagnos-
tic approach for human brucellosis [75,76]. Lin GZ et al.
also reported a nested PCR for the laboratory diagnosis of
human brucellosis [77]. Moreover, a semi-nested PCR for
diagnosis of human brucellosis were developed and evalu-
ated with whole blood. The primers were from IS6501 and
bcsp31 genes [78]. We are now performing nested PCR
combined with real-time PCR approach for the diagnosis of
human brucellosis with the primers from bcsp31 and
VirB11 genes. B. abortus and B. melitensis can be rapidly
identified. The results have not been reported. According
to the results, this assay was sensitive and could be used
for the diagnosis of human brucellosis in the clinical
laboratory.
However, the nested PCR and semi-nested PCR have
some disadvantages. For example, the assays increased
risk of primer dimerization and cross-react of PCR prod-
ucts. In addition, the nested PCR or semi-nested PCR
will only identify a set of Brucella bacteria, not a single
specific species.
Other PCR-based assays
In addition to standard PCR and its derivatives (nested
and semi-nested, multiplex and real-time PCR), there are
other significant PCR-based assays have been developed in
the last years. Fekete et al. developed the arbitrarily primed
polymerase chain reaction (AP-PCR) to distinguish 25
different Brucella strains according to the banding pat-
terns of their amplified DNA on agarose gels. The degrees
of relatedness among these strains of the genus Brucella
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[79]. In 1994, AMOS PCR assays were used to identify
vaccine strains from strains that cause infections based on
the number and sizes of products amplified by PCR
[80,81]. In 1996, Tcherneva et al. reported the REP-PCR
as a promising fingerprinting method for the evaluation of
Brucella outbreak [82]. Also, various PCR-RFLPs display
sufficient polymorphism to distinguish Brucella species
and biovars, and can serve as tools for diagnostic, epi-
demiological, taxonomic, and evolutionary studies [83].
In addition, Multiple-locus variable-number tandem-repeat
assays (MLVA) were used to study the molecular epi-
demiological characterization of Brucella isolates from
humans [84]. PCR methods have been used success-
fully to identify all Brucella species and most of the
biovars, offering an improvement over conventional
molecular genotyping methods [85,86]. Furthermore,
Bruce-ladder multiplex PCR assay was evaluated using
625 Brucella strains. This method can differentiate in a
single step all of the classical Brucella species, includ-
ing strains from marine mammals and the S19, RB51,
and Rev.1 vaccine strains [67]. Recently, the microfluidic
Lab-on-Chip was also proposed as a rapid and specific
detection method for the characterization of Brucella iso-
lates [87,88].
PCR-based assays were shown to be valuable tools for
detecting Brucella strains. PCR approaches have several
advantages for the diagnosis of human brucellosis, such
as speed, safety, high sensitivity and specificity [89]. This
technique might be considered complementary to the trad-
itional methods and followed up by serology and/or culture
[90]. However, its disadvantages such as the higher cost, is-
sues of quality control and quality assurance must be fur-
ther evaluated on clinical samples before PCR can be used
in routine laboratory testing for human brucellosis [9,91].
Evaluation of PCR results for treatment and follow-up
of patients
Most patients with brucellosis suffer a relapse after re-
ceive the duration and combination of antibiotic therapy.
Therefore, it is necessary to evaluate the progress towards
therapeutic failure or relapse [50]. The conventional
methods are difficult for the diagnosis of these relapses.
Several previous studies reported the applications of
PCR for the diagnosis of post treatment follow-up and
relapses. Queipo-Ortuño MI et al. examined the useful-
ness of PCR assay in post treatment follow-up and relapse
of patients with brucellosis. They showed positive PCR
tests for the relapse as well as negative once the relapse
treatment was completed [26,30]. Nimri LF obtained the
positive PCR results in the relapse cases, indicating that
the assay could be a useful tool to confirm a relapse in
cases of a treated brucellosis [21]. Navarro E et al. also
developed a real-time PCR assay to monitor the evolutionof Brucella melitensis DNA load in blood during therapy
and post-therapy follow-up in patients with brucellosis.
This assay showed 100% analytical sensitivity for both ini-
tial infections and relapses [92]. Moreover, Mitka S et al.
showed that PCR assays were negative in all follow-up
samples from patients who had completed a successful
treatment and were positive in all follow-up samples from
patients who had relapses in the first year after therapy,
including the times of the relapses [14]. However, dead
phagocytosed bacteria may present in the circulating
mononuclear cells in certain patients who have concluded
successful treatment. Because PCR cannot differentiate
between DNA from live and dead organisms, therefore,
the ability to amplify the DNA of Brucella DNA from
dead or phagocytized cells should be considered when
interpreting the results.
Conclusions
At present, PCR-based assays could allow rapid and
more-sensitive identification of Brucella genus at the
species and at the biovar level, compared with traditional
techniques. The implementation of PCR-based assays into
the clinical setting will likely improve therapeutic outcomes.
However, PCR protocols lack standardization. As new
methods for Brucella spp. identification and typing, PCR
tests are still being developed and still await validation for
use with clinical samples. For instance, the sensitivity and
specificity of most PCR-based methods is associated
with inhibitors in DNA samples such as EDTA, RNase
or DNase, heme, heparin, phenol, and probably a host
of other reagents. There is still a great deal of work re-
quired for standardization before any of these methods
may be used in routine laboratory testing for brucellosis.
Future studies should focus on the integration of these
techniques into clinical decision making.
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